Skip to search.
 FTSE 100 Up 0.33%

More On OXB.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

  • Headlines
  • Company Events

Company

Analyst Coverage

Ownership

Financials

Oxford BioMedica PLC (OXB.L)

-LSE Ticker: 664815/ISIN: GB0006648157
3.91 Up 0.12(3.03%) 9 Dec 17:45
Prev Close:3.79
Open:4.01
Bid:3.00 x 2513500
Ask:N/A x 11600000
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:3.70 - 4.05
52wk Range:2.98 - 8.45
Volume:2,455,086
Avg Vol (3m):5,285,790
Market Cap:120.37m
P/E (ttm):N/A
EPS (ttm):-0.01
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Headlines

  • No Headlines available for OXB.L at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):420.61
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.53
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Oxford BioMedica plc, a biopharmaceutical company, researches, develops, and produces gene and cell therapy products for the treatment of ocular, central nervous system (CNS), and cancer indications. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback